About
Contact & Profiles
A5086449076
Research Areas
- PARP inhibition in cancer therapy
- Immune Cell Function and Interaction
- Ginseng Biological Effects and Applications
Guangzhou University of Chinese Medicine
2022
Non-small cell lung cancer (NSCLC) patients are particularly vulnerable to the Coronavirus Disease-2019 (COVID-19). Currently, no anti-NSCLC/COVID-19 treatment options available. As ginsenoside Rg3 is beneficial NSCLC and has been identified as an entry inhibitor of virus, this study aims explore underlying pharmacological mechanisms for with COVID-19.Based on a large-scale data mining systemic biological analysis, investigated target genes, processes, mechanisms, immune implications...
10.1016/j.jgr.2022.09.006
article
EN
cc-by-nc-nd
Journal of Ginseng Research
2022-10-12
Coming Soon ...